Study Watch vs KardiaAI
AI Verdict
Choose Study Watch if…
Choose the Verily Study Watch if your primary need is continuous, multi-sensor physiological data collection for rigorous clinical research studies. This prescription-only wearable is ideal for researchers requiring long-term, non-invasive monitoring of various parameters like ECG, heart rate, and movement, with data processed securely in a cloud platform, to gain comprehensive insights into patient physiology.
View Study Watch →Choose KardiaAI if…
Choose KardiaAI if you require an FDA-cleared, AI-powered software library to enhance the diagnostic capabilities of existing ECG devices or platforms. This tool is specifically designed for accurate, automated analysis of ambulatory ECG rhythms, providing detection for a wide range of cardiac conditions like AFib, bradycardia, and various ectopies, making it ideal for integrating advanced, medical-grade ECG analysis into other applications or workflows.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Study Watch | KardiaAI |
|---|---|---|
| Pricing | Unknown | Subscription-based for advanced features and services. |
| Deployment | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). | Mobile app, cloud-based. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Study WatchThe Verily Study Watch offers continuous, non-invasive physiological monitoring with a long battery life, making it highly usable for passive, long-term data collection by end-users in a research setting. Its wearable form factor minimizes user intervention. In contrast, KardiaAI is an AI software library whose direct end-user usability depends on its integration into other platforms, often requiring active engagement with a separate device for ECG readings.
Clinical Value
KardiaAIKardiaAI provides FDA-cleared, medical-grade AI analysis for direct detection of multiple specific cardiac conditions from ECGs, offering immediate and actionable diagnostic information for patient management. While Study Watch provides continuous physiological data for clinical research, its direct diagnostic output is less specified compared to KardiaAI's precise rhythm interpretations.
Pricing & Value
KardiaAIKardiaAI offers transparent, subscription-based pricing for its integrated services, allowing potential users to clearly understand and evaluate the cost-effectiveness of its AI capabilities. Study Watch's pricing is not publicly available, making it impossible for external parties to assess its value proposition or compare costs.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness. Study Watch, backed by Verily (Google) and designed for clinical research partnerships, offers robust infrastructure, HIPAA compliance, and a BAA for enterprise-level research deployments. KardiaAI, as an API library with HIPAA compliance and BAA, is inherently designed for flexible integration into diverse enterprise healthcare IT systems and mobile applications.
Innovation
Study WatchStudy Watch's innovation lies in its multi-sensor, continuous physiological monitoring capabilities, collecting diverse data types (ECG, heart rate, electrodermal activity, inertial movements) over extended periods in a prescription-only wearable for research. This represents a broader scope of innovation in multi-modal data capture for precision health. KardiaAI innovates with its sophisticated, medical-grade AI algorithms for precise ECG rhythm analysis, but Study Watch's hardware and data collection breadth are more expansive.
Support & Docs
KardiaAIAs an API library, KardiaAI inherently necessitates comprehensive developer documentation, SDKs, and support channels to facilitate its integration and adoption by third-party developers and enterprises. While Study Watch, intended for clinical research and partnerships, likely offers direct, bespoke support to its partners, public documentation or general support channels are not indicated.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Study Watch | KardiaAI |
|---|---|---|
| Primary Function | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Company | Verily Life Sciences | AliveCor |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI |
| Specialties | Cardiology, Neurology, Sleep Medicine | Cardiology, Emergency Medicine, Internal Medicine |
| Key Detections/Analysis | Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), On-demand single-channel ECG, Irregular pulse monitor. | AI-powered ECG analysis, Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE). |
Videos
Demos, reviews, and walkthroughs featuring Study Watch and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Study Watch or KardiaAI
Backers
Who funded each tool's parent company.